BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 7398972)

  • 1. [Immunoglobulin E in cutaneous lymphomas and in parapsoriasis en plaques (Brocq) (author's transl)].
    Schlaeger M
    Dermatologica; 1980; 161(1):1-7. PubMed ID: 7398972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [IgE and cellular immunity in cutaneous lymphomas (author's transl)].
    Guilhou JJ; Clot J; Robinet-Lévy M; Meynadier J
    Ann Dermatol Venereol; 1977; 104(8-9):533-7. PubMed ID: 303883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ identification and enumeration of T lymphocytes in cutaneous T-cell lymphomas by demonstration of granular activity of acid non-specific esterase.
    Sterry W; Steigleder GK; Pullmann H
    Br J Dermatol; 1980 Jul; 103(1):67-72. PubMed ID: 6968580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressor T cells in mycosis fungoides and so-called premycotic eruptions.
    Wassermann J; Biberfeld G; Baral E; Blomgren H; Thyresson N; Brehmer-Andersson E
    Acta Derm Venereol; 1980; 60(2):139-43. PubMed ID: 6155020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Parapsoriasis en plaques and mycosis fungoides: an unclear relationship].
    Pimpinelli N; Santucci M; Ghersetich I; Brogelli L; Moretti S
    G Ital Dermatol Venereol; 1988; 123(7-8):329-35. PubMed ID: 3066747
    [No Abstract]   [Full Text] [Related]  

  • 6. OKT 9 reactivity in mycosis fungoides and large plaque (atrophic) parapsoriasis.
    McMillan EM; Wasik R; Peters S; Jackson I; Stoneking L; Everett MA
    Cancer; 1983 Apr; 51(8):1403-7. PubMed ID: 6337701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of HECA-452 in parapsoriasis and mycosis fungoides.
    Di Trolio R; Di Lorenzo G; Barbiero E; Iacono A; Franco R; D Armiento M; Delfino M; D Armiento FP
    Int J Immunopathol Pharmacol; 2006; 19(1):105-10. PubMed ID: 16569348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective study of the probability of the evolution of parapsoriasis en plaques into mycosis fungoides.
    Väkevä L; Sarna S; Vaalasti A; Pukkala E; Kariniemi AL; Ranki A
    Acta Derm Venereol; 2005; 85(4):318-23. PubMed ID: 16191852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The difference forms of "parapsoriasis en plaques". A report of 90 cases (author's transl)].
    Bonvalet D; Colau-Gohm K; Belaïch S; Civatte J; Degos R
    Ann Dermatol Venereol; 1977 Jan; 104(1):18-25. PubMed ID: 843023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD13 and TCR clone: markers of early mycosis fungoides.
    Bernier C; Nguyen JM; Quéreux G; Renault JJ; Bureau B; Dreno B
    Acta Derm Venereol; 2007; 87(2):155-9. PubMed ID: 17340024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of monocyte-mediated, antibody-dependent cytotoxicity in mycosis fungoides.
    Kragballe K; Herlin T; Ellegaard J
    Arch Dermatol; 1983 Mar; 119(3):203-6. PubMed ID: 6824357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunocytological study of cutaneous malignant lymphomas. Classification (author's transl)].
    Souteyrand P; Thivolet J; Alario A; Schmitt D; Perrot H
    Dermatologica; 1978; 157(5):268-81. PubMed ID: 150348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Do you classify parapsoriasis en plaques as mycosis fungoides?].
    Ann Dermatol Venereol; 1993; 120(12):935-8. PubMed ID: 8074362
    [No Abstract]   [Full Text] [Related]  

  • 14. From inflammation to neoplasia: mycosis fungoides evolves from reactive inflammatory conditions (lymphoid infiltrates) transforming into neoplastic plaques and tumors.
    Burg G; Dummer R; Haeffner A; Kempf W; Kadin M
    Arch Dermatol; 2001 Jul; 137(7):949-52. PubMed ID: 11453817
    [No Abstract]   [Full Text] [Related]  

  • 15. Parapsoriasis en plaques and mycosis fungoides.
    Khan M
    Z Hautkr; 1974 Jun; 49(12):547-54. PubMed ID: 4853533
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies of cutaneous malignant lymphoma--especially about T gamma cell (author's transl)].
    Shimokawa Y
    Nihon Hifuka Gakkai Zasshi; 1982 Feb; 92(2):149-55. PubMed ID: 6979648
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoclonal antibodies and cutaneous T cell lymphoma. Theoretical and practical considerations.
    McMillan EM
    J Am Acad Dermatol; 1985 Jan; 12(1 Pt 1):102-14. PubMed ID: 2579987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of lymphoid cells in myocosis fungoides, Sézary's syndrome and parapsoriasis en plaques.
    Schmoeckel C; Burg G; Braun-Falco O
    Arch Dermatol Res; 1979 Feb; 264(1):17-28. PubMed ID: 443858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Skin lymphoma morbidity over a 10-year period (based on data from the Rostov-on-Don Skin Clinic)].
    Voloshin RN
    Vestn Dermatol Venerol; 1990; (6):44-6. PubMed ID: 2145710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parapsoriasis with hyper-IgE.
    Downham TF; Savoy LB
    Int J Dermatol; 1979 Oct; 18(8):649-54. PubMed ID: 389842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.